managing hereditary angioedema
DESCRIPTION
Managing Hereditary Angioedema. Setting the Stage Burden of Disease in HAE . Burden of Disease in HAE (cont). C1 Esterase Inhibitor for Treatment of Laryngeal Attacks in HAE. Other Therapies Approved For On-Demand Treatment of HAE Attacks. Ecallantide Efficacy. Icatibant FAST-3 Trials. - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Managing Hereditary Angioedema](https://reader036.vdocument.in/reader036/viewer/2022081517/56815f8f550346895dce9281/html5/thumbnails/1.jpg)
Managing Hereditary Angioedema
![Page 2: Managing Hereditary Angioedema](https://reader036.vdocument.in/reader036/viewer/2022081517/56815f8f550346895dce9281/html5/thumbnails/2.jpg)
![Page 3: Managing Hereditary Angioedema](https://reader036.vdocument.in/reader036/viewer/2022081517/56815f8f550346895dce9281/html5/thumbnails/3.jpg)
Setting the StageBurden of Disease in HAE
![Page 4: Managing Hereditary Angioedema](https://reader036.vdocument.in/reader036/viewer/2022081517/56815f8f550346895dce9281/html5/thumbnails/4.jpg)
Burden of Disease in HAE (cont)
![Page 5: Managing Hereditary Angioedema](https://reader036.vdocument.in/reader036/viewer/2022081517/56815f8f550346895dce9281/html5/thumbnails/5.jpg)
C1 Esterase Inhibitor for Treatment of Laryngeal Attacks in HAE
![Page 6: Managing Hereditary Angioedema](https://reader036.vdocument.in/reader036/viewer/2022081517/56815f8f550346895dce9281/html5/thumbnails/6.jpg)
Other Therapies Approved For On-Demand Treatment of HAE Attacks
![Page 7: Managing Hereditary Angioedema](https://reader036.vdocument.in/reader036/viewer/2022081517/56815f8f550346895dce9281/html5/thumbnails/7.jpg)
Ecallantide Efficacy
![Page 8: Managing Hereditary Angioedema](https://reader036.vdocument.in/reader036/viewer/2022081517/56815f8f550346895dce9281/html5/thumbnails/8.jpg)
Icatibant FAST-3 Trials
![Page 9: Managing Hereditary Angioedema](https://reader036.vdocument.in/reader036/viewer/2022081517/56815f8f550346895dce9281/html5/thumbnails/9.jpg)
Icatibant Reinjection Rates
![Page 10: Managing Hereditary Angioedema](https://reader036.vdocument.in/reader036/viewer/2022081517/56815f8f550346895dce9281/html5/thumbnails/10.jpg)
C1 Inhibitor Use in Children
![Page 11: Managing Hereditary Angioedema](https://reader036.vdocument.in/reader036/viewer/2022081517/56815f8f550346895dce9281/html5/thumbnails/11.jpg)
C1 Inhibitor Use in Children (cont)
![Page 12: Managing Hereditary Angioedema](https://reader036.vdocument.in/reader036/viewer/2022081517/56815f8f550346895dce9281/html5/thumbnails/12.jpg)
C1 Inhibitor Use in Children for Short-term Prophylaxis
![Page 13: Managing Hereditary Angioedema](https://reader036.vdocument.in/reader036/viewer/2022081517/56815f8f550346895dce9281/html5/thumbnails/13.jpg)
MacGinnitie et al Study of Ecallantide Treatment for Pediatric
HAE
![Page 14: Managing Hereditary Angioedema](https://reader036.vdocument.in/reader036/viewer/2022081517/56815f8f550346895dce9281/html5/thumbnails/14.jpg)
Treatment Outcomes With Ecallantide vs Placebo
![Page 15: Managing Hereditary Angioedema](https://reader036.vdocument.in/reader036/viewer/2022081517/56815f8f550346895dce9281/html5/thumbnails/15.jpg)
C1 Inhibitor Dose-escalation Study
![Page 16: Managing Hereditary Angioedema](https://reader036.vdocument.in/reader036/viewer/2022081517/56815f8f550346895dce9281/html5/thumbnails/16.jpg)
C1 Inhibitor Dose-escalation Study (cont)
![Page 17: Managing Hereditary Angioedema](https://reader036.vdocument.in/reader036/viewer/2022081517/56815f8f550346895dce9281/html5/thumbnails/17.jpg)
The Successes in 14 Patients
![Page 18: Managing Hereditary Angioedema](https://reader036.vdocument.in/reader036/viewer/2022081517/56815f8f550346895dce9281/html5/thumbnails/18.jpg)
Treatment Failures
![Page 19: Managing Hereditary Angioedema](https://reader036.vdocument.in/reader036/viewer/2022081517/56815f8f550346895dce9281/html5/thumbnails/19.jpg)
Impact of HAE Prophylaxis on QoL
![Page 20: Managing Hereditary Angioedema](https://reader036.vdocument.in/reader036/viewer/2022081517/56815f8f550346895dce9281/html5/thumbnails/20.jpg)
![Page 21: Managing Hereditary Angioedema](https://reader036.vdocument.in/reader036/viewer/2022081517/56815f8f550346895dce9281/html5/thumbnails/21.jpg)
Effects of C1 Inhibitor Prophylaxis vs On-demand Therapy on QoL
![Page 22: Managing Hereditary Angioedema](https://reader036.vdocument.in/reader036/viewer/2022081517/56815f8f550346895dce9281/html5/thumbnails/22.jpg)
SF-36 Norm-based Domain and Component Summary Scores
![Page 23: Managing Hereditary Angioedema](https://reader036.vdocument.in/reader036/viewer/2022081517/56815f8f550346895dce9281/html5/thumbnails/23.jpg)
Recommendations for Managing HAE
![Page 24: Managing Hereditary Angioedema](https://reader036.vdocument.in/reader036/viewer/2022081517/56815f8f550346895dce9281/html5/thumbnails/24.jpg)
Recommendations for Managing HAE (cont)
![Page 25: Managing Hereditary Angioedema](https://reader036.vdocument.in/reader036/viewer/2022081517/56815f8f550346895dce9281/html5/thumbnails/25.jpg)
![Page 26: Managing Hereditary Angioedema](https://reader036.vdocument.in/reader036/viewer/2022081517/56815f8f550346895dce9281/html5/thumbnails/26.jpg)
![Page 27: Managing Hereditary Angioedema](https://reader036.vdocument.in/reader036/viewer/2022081517/56815f8f550346895dce9281/html5/thumbnails/27.jpg)
Abbreviations
![Page 28: Managing Hereditary Angioedema](https://reader036.vdocument.in/reader036/viewer/2022081517/56815f8f550346895dce9281/html5/thumbnails/28.jpg)
References
![Page 29: Managing Hereditary Angioedema](https://reader036.vdocument.in/reader036/viewer/2022081517/56815f8f550346895dce9281/html5/thumbnails/29.jpg)
References (cont)
![Page 30: Managing Hereditary Angioedema](https://reader036.vdocument.in/reader036/viewer/2022081517/56815f8f550346895dce9281/html5/thumbnails/30.jpg)
References (cont)
![Page 31: Managing Hereditary Angioedema](https://reader036.vdocument.in/reader036/viewer/2022081517/56815f8f550346895dce9281/html5/thumbnails/31.jpg)
References (cont)
![Page 32: Managing Hereditary Angioedema](https://reader036.vdocument.in/reader036/viewer/2022081517/56815f8f550346895dce9281/html5/thumbnails/32.jpg)
![Page 33: Managing Hereditary Angioedema](https://reader036.vdocument.in/reader036/viewer/2022081517/56815f8f550346895dce9281/html5/thumbnails/33.jpg)
![Page 34: Managing Hereditary Angioedema](https://reader036.vdocument.in/reader036/viewer/2022081517/56815f8f550346895dce9281/html5/thumbnails/34.jpg)